<DOC>
	<DOCNO>NCT01923272</DOCNO>
	<brief_summary>The purpose multi-center , prospective , double-blind , randomize , sham-controlled pilot study study feasibility collect additional preliminary clinical data relate safety clinical benefit non-invasive vagal nerve stimulation AlphaCore device treatment prevention exercise-induced bronchoconstriction , support development approval large pivotal study . The objective study ( 1 ) gather preliminary safety efficacy data AlphaCore device treatment EIB ( Treatment Visit 1 ) prevention EIB ( Treatment Visit 2 ) , ( 2 ) validate sham device ( blind effect , placebo effect ) effective control use future clinical study , ( 3 ) support development approval pivotal study , confirm data collection method endpoint definition , confirm appropriateness subject follow plan .</brief_summary>
	<brief_title>Non-Invasive Neurostimulation Vagus Nerve With AlphaCore Device Relief EIB</brief_title>
	<detailed_description>Study Design Summary Study Type : Prospective , randomize ( allocated 1:1 ) , double-blind , sham-controlled pilot study Sample Size : Up 60 subject Number Sites : Up 10 site Anticipated Study Duration : 8 month Number Study Visits : Three : 1 . Screening Visit 2 . Treatment Visit 1 - treatment AlphaCore ( active sham ) exercise challenge 3 . Treatment Visit 2 - Prophylactic treatment AlphaCore ( active sham ) prior exercise challenge There telephone follow-up call within 12-24 hour treatment visit occur well 7-day ( +/- 3 day ) final phone call Treatment Visit 2 . # Study Arm ( ) : Two Arms 1 . Active Treatment AlphaCore Device 2 . Sham Treatment inactive sham device Blinding Double blind . The subject blind treatment assignment . Due treat Investigator 's designee designee 's ability detect difference muscle effect active sham device , treat Investigator designee blind . Data assessor blind .</detailed_description>
	<criteria>1 . Is able give write Informed Consent . 2 . Is ages 18 60 year , male female . 3 . Has history breathlessness exertion . 4 . Normally control prevents EIB use short act betaagonist ( SABA ) . 5 . Is willing take urine pregnancy test female childbearing potential agrees become pregnant duration study . 1 . Has condition would prevent otherwise inhibit reasonable exertion require induce bronchoconstriction . 2 . Is unable perform acceptablequality spirometry ( FEV1 &lt; 75 % predict ) . 3 . Is currently use Beta2adrenergic blocker ( i.e . propranolol ) . 4 . Has smoke within past year , and/or 10 pack year history . 5 . Has history lung cancer , chronic obstructive pulmonary disease ( COPD ) , comorbidity associate irreversible narrowing airway . 6 . Has abscess infection lesion ( include lymphadenopathy ) AlphaCore treatment site . 7 . Has know suspect moderate severe atherosclerotic cardiovascular disease , carotid artery disease ( e.g . bruits history TIA CVA ) . 8 . Has clinically significant irregular heart rate rhythm . 9 . Has uncontrolled hypertension ( systolic bp &gt; 200 diastolic bp &gt; 100 ) , recent ( within last 3 month ) heart attack , recent ( within last 3 month ) stroke , know aortic aneurysm , congestive heart failure ( CHF ) . 10 . Is currently implanted electrical and/or neurostimulator device , include limited cardiac pacemaker , defibrillator , vagal neurostimulator , deep brain stimulator , spinal stimulator , bone growth stimulator , cochlear implant . 11 . Has history carotid endarterectomy , vagotomy ( right bilateral ) , dysaesthesia vascular neck surgery right side . 12 . Has implant metal cervical spine hardware . 13 . Has recent repeat history syncope . 14 . Has recent repeat history seizure . 15 . Has condition would interfere VAS Dyspnea selfassessment . 16 . Is pregnant nursing , childbearing potential unwilling use accept form birth control . 17 . Is participate therapeutic clinical investigation participate clinical trial precede 30 day . 18 . Belongs vulnerable population condition ability provide inform consent , comply followup requirement , provide selfassessments compromise ( e.g. , homeless , developmentally disabled , prisoner ) . 19 . Is employee relative Investigator clinical study site .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>